Este artículo solo puede leerse en
pdf
Bibliografía
[1]
Identificación y tratamiento de los pacientes com miocariopatía hipertrófica y riesgo de muertesúbita. Rev Esp Cardiol 2000; 53: 123-130.
[2]
Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and haemodynamic features. AmJ Cardiol 1981; 47: 532-538.
[3]
Arrhythmia, sudden death, and clinical risk stratification in hypertrophic cardiomyopathy. En: Zipes DP,Jalife J, editores. Cardiac electrophysiology: from cell to bedside(3.ª ed.). Philadelphia: W.B. Saunders Company, 2000; 555-562.
[4]
Prognostic determinants in hypertrophic cardiomyopathy: prospective evalua-tionof a therapeutic strategy based on clinical, Holter, hemodyna-mic,and electrophysiological findings. Circulation 1992; 86: 730-740.